Sign up
Log in
Buy these ASX dividend stocks for 5% to 10% yields: Experts
Share
Listen to the news

For investors looking for passive income, the Australian share market has a multitude of options.

To narrow things down, let's look at three ASX dividend stocks that experts think could be in the buy zone right now.

Here's what they are recommending to clients:

Centuria Industrial REIT (ASX: CIP)

The first ASX dividend stock that could be a buy is Centuria Industrial REIT.

It is one of Australia's leading industrial real estate companies. At the last count, its portfolio comprised 87 high-quality, fit-for-purpose industrial assets worth a collective $3.89 billion. These assets are situated in key in-fill locations and close to key infrastructure.

The team at UBS is feeling positive about the company and its outlook. It believes it is positioned to reward shareholders with dividends per share of 16.8 cents in FY 2026 and then 17.9 cents in FY 2027. Based on its current share price of $3.33, this equates to dividend yields of 5% and 5.4%, respectively.

The broker has a buy rating and $3.95 price target on its shares.

IPH Ltd (ASX: IPH)

Another ASX dividend stock that experts are recommending is IPH.

It is a global intellectual property services group that helps clients across the world protect their patents, trademarks, and intellectual property across multiple jurisdictions.

The company's defensive business, strong cash conversion, and disciplined capital management have allowed the company to pay generous dividends over the past decade.

The good news is that Morgans expects this trend to continue. It is forecasting fully franked dividends of 37 cents per share in both FY 2026 and FY 2027. Based on its current share price of $3.60, this would mean dividend yields greater than 10% for both years.

Morgans has a buy rating and $6.05 price target on its shares.

Sonic Healthcare Ltd (ASX: SHL)

A third ASX dividend stock that is rated highly by experts is Sonic Healthcare.

It is one of the world's leading healthcare providers with operations spanning laboratory medicine, pathology, radiology, and primary care medical services.

After a tough period following the end of COVID testing, Bell Potter believes the company is now positioned for sustainable growth.

This is expected to support the payment of partially franked dividends per share of $1.09 per share in FY 2026 and $1.11 per share in FY 2027. With Sonic shares trading at $22.14, this equates to dividend yields of 4.9% and 5%.

Bell Potter has a buy rating and a $33.30 price target on its shares.

The post Buy these ASX dividend stocks for 5% to 10% yields: Experts appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended IPH Ltd and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.